HDAC-IN-49 is a potent unselective HDAC ( HDAC ) inhibitor with IC 50 s of 13 nM, 14 nM, 21 nM, 1880 nM, and 10 nM for HDAC1 , HDAC2 , HDAC3 , HDAC4 , and HDAC6 . HDAC-IN-49 demonstrates prominent antileukemic activity with low cytotoxic activity toward healthy cells.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Signaling Pathways > HDAC
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.